Previous Article | Next Article ![]()
Journal of Bacteriology, January 2002, p. 191-199, Vol. 184, No. 1
0021-9193/01/$04.00+0 DOI: 10.1128/JB.184.1.191-199.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
School of Biological Sciences, Royal Holloway University of London, Egham, Surrey, TW20 0EX,1 Department of Chemistry, University of York, York, Y010 5DD, United Kingdom2
Received 19 July 2001/ Accepted 8 October 2001
|
|
|---|
K checkpoint of Bacillus subtilis. This regulatory mechanism coordinates late gene expression during development in this organism and we have recently shown SpoIVB to be a serine peptidase. SpoIVB signals by transiting a membrane, undergoing self-cleavage, and then by an unknown mechanism activating a zinc metalloprotease, SpoIVFB, which cleaves pro-
K to its active form,
K, in the outer mother cell chamber of the developing cell. In this work we have characterized the serine peptidase domain of SpoIVB. Alignment of SpoIVB with homologues from other spore formers has allowed site-specific mutagenesis of all potential active site residues within the peptidase domain. We have defined the putative catalytic domain of the SpoIVB serine peptidase as a 160-amino-acid residue segment at the carboxyl terminus of the protein. His236 and Ser378 are the most important residues for proteolysis, with Asp363 being the most probable third member of the catalytic triad. In addition, we have shown that mutations at residues Asn290 and His394 lead to delayed signaling in the
K checkpoint. The active site residues suggest that SpoIVB and its homologues from other spore formers are members of a new family of serine peptidases of the trypsin superfamily. |
|
|---|
K checkpoint) which coordinates gene expression during the later stages of spore formation in Bacillus subtilis (36). Proteolytic activity has been demonstrated in vitro as well as in vivo and this activity is essential to SpoIVBs role as the signaling molecule that activates
K.
SpoIVB is synthesized in the forespore chamber of the sporulating cell and is secreted across the inner forespore membrane. At this point SpoIVB becomes proteolytically active and self-cleaves into at least three distinct species, of 46, 45, and 44 kDa. These are thought to be the active forms which signal proteolytic processing of the transcription factor
K. Signaling leads to activation of a processing complex embedded in the outer forespore membrane which cleaves the N-terminal leader sequence (the pro sequence) from pro-
K. The sigma factor
K is then competent to direct the final stages of gene expression in the mother cell. Reminiscent of the blood clotting cascades, SpoIVB is also subject to secondary proteolysis, which presumably inactivates SpoIVB by cleaving the active species into 42- and 40-kDa forms (36). How SpoIVB activates processing of pro-
K is not yet clear, but genetic evidence has shown that SpoIVB most likely interacts with one or more members of the pro-
K processing complex which is embedded in the outer forespore membrane (7, 8, 10). These proteins are SpoIVFB, a zinc metalloprotease which cleaves pro-
K (10, 28), and the BofA and SpoIVFA proteins, both of which are required to inhibit activity of SpoIVFB (25, 26). Interestingly, both SpoIVFA and BofA inhibit SpoIVFB using their C termini, which are exposed to the space between the inner and outer forespore membranes, and removal of either the BofA or SpoIVFA C terminus renders SpoIVFB constitutively active (12, 27, 34).
SpoIVB also carries a PDZ domain in the N-terminal half of the polypeptide (21). PDZ domains are used by signaling molecules for protein targeting and protein-protein interactions (18, 21, 22). In other work we have shown that this SpoIVB PDZ domain could be involved in multiple interactions including oligomerization, interaction with an inhibitor protein, BofC, and activating processing of pro-
K (14). The bacterial Prc (also called Tsp) and HtrA (also called DegP) serine peptidase families carry both a PDZ and peptidase domain (19, 21) and it has been shown that substrate recognition is mediated by the PDZ domain (3). An attractive model for how SpoIVB signals is that SpoIVB uses its PDZ domain to target one or both of the SpoIVFB inhibitors (SpoIVFA and BofA) followed by cleavage of the C termini of these inhibitors. An alternative role for the serine peptidase activity is simply to enable secretion of SpoIVB across the inner forespore membrane since SpoIVB does not carry a normal N-terminal signal sequence.
Homologues of SpoIVB proteins have been identified in a number of spore-forming organisms, revealing a string of strictly conserved residues. In this work we have examined the serine peptidase domain of SpoIVB with the aim of defining amino acid residues involved in catalysis. It appears that SpoIVB is a distinctive variant of trypsin-like proteases and that PDZ domains commonly have a specialized role in bacteria for the activation and substrate recognition of proteases that have to cross a membrane.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. B. subtilis strains
|
Site-specific mutagenesis.
Two oligonucleotide primers were used to amplify by PCR a 1,429-bp spoIVB product using chromosomal DNA from B. subtilis strain PY79 as a template. The primers were P1 (5'-TTATAACGTTCGTGCACATCCATTCGTTC-3'), annealing to nucleotides -146 to -127 from the spoIVB start codon, and P2 (5'-AACGGATCCAGTCAGCTTGCTTTTTCTTTTCC-3'), which annealed to the spoIVB stop codon (bold) and a further 18 bases downstream. The PCR product contained HindIII (P1) and BamHI (P2) restriction sites (underlined), enabling direct cloning into pBluescript II KS(+). The resultant clone, pNH252, was sequenced completely to verify the presence of an unmodified spoIVB cistron. Next, mutations were created with mismatched oligonucleotides using the method of Kunkel as described in Sambrook et al. (29). pBluescript clones were verified by the presence of a single base change by DNA sequencing. Finally, the spoIVB genes were subcloned as 1.4-kb HindIII-BamHI fragments into pDG364 (11) and are listed in Table 1. pDG364 enables the insertion of cloned DNA, in trans, at the amyE locus by a double-crossover marker replacement. In each case we linearized the pDG364 subclones by digestion with XhoI and introduced them into SC1836 (spoIVB
::spc) cells by DNA-mediated transformation followed by selection for chloramphenicol resistance (Cmr; encoded by pDG364). Insertion at the amyE locus was confirmed by testing for an Amy- phenotype (failure to digest starch) as described elsewhere (11). We also constructed two isogenic control strains, NH578 (spoIVB
::spc amyE::spoIVB+) and NH577 (spoIVB
::spc amyE::pDG364). NH578 was created by integrating a pDG364 subclone, pNH470, carrying the full-length, 1,429-bp, wild-type spoIVB gene into the amyE locus and NH577 was created by integrating the unmodified pDG364 plasmid into the chromosome by a double-crossover recombination event at amyE.
Western blotting analysis. Samples (1 ml) were taken from sporulating cultures and cells were harvested by centrifugation and frozen in liquid N2. To break cells, pellets were suspended in 50 µl of TS buffer (25 mM Tris-HCl [pH 7.4], 0.1 M NaCl) containing lysozyme (0.2 µg/ml) and incubated for 10 min on ice. Fifty microliters of 2x sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading dye was then added and the samples were sonicated for 10 s before gel loading (approximately 20 µl of sample/well). Immunoblotting of sporulating extracts with polyclonal antiserum to SpoIVB was performed as described previously (12, 36).
Expression of SpoIVB templates in Escherichia coli.
A pET28b clone (p
IVB) containing a truncated SpoIVB template starting at codon 37 of spoIVB and fused to the ribosome binding site and ATG start codon of the pET vector has been described (36). Identical clones were made carrying mutant spoIVB templates spoIVBHN236 (p
IVBHN236), spoIVBDL242 (p
IVBDL242), spoIVBDL363 (p
IVBDL363), and spoIVBSK378 (p
IVBSK378).
|
|
|---|
![]() View larger version (57K): [in a new window] |
FIG. 1. Protein sequence alignment of SpoIVB peptidase domains. Sequences were aligned using ClustalW (32) and the figure was generated using ALSCRIPT (2). Abbreviations: Bsub, B. subtilis (accession no. P17896, residues 187 to 425); Bhal, B. halodurans (Q9K975, 197 to 437); Cdif, C. difficile (Q46028, 124 to 352); Bant, B. anthracis (www.tigr.org/tdb/mdb/mdbinprogress.html); Chyd, C. hydrogenoformans (www.tigr.org/tdb/mdb/mdbinprogress.html); Bste, B. stearothermophilus (www.genome.ou/bstearo.html); Cace, C. acetobutylicum (www.genomecorp.com/genesequences/clostridium/clospage.html). Sequences without accession numbers were derived from the unfinished genome DNA sequences. Strictly conserved amino acids are boxed, positions of the SpoIVB mutants described are labeled and numbered, and the putative catalytic triad residues are highlighted with an asterisk.
|
|
View this table: [in a new window] |
TABLE 2. spoIVB alleles
|
::spc. Using isogenic control strains with (NH578) or without (NH577) a copy of the wild-type spoIVB gene at amyE we examined sporulation and signaling.
As shown in Table 2 there were three distinct classes of mutant phenotype. The first group (group I) consisted of spoIVBHN236, spoIVBHF236, spoIVBDL242, spoIVBDL363, spoIVBSA378, and spoIVBSK378 mutants which caused a severe effect on spore formation, with the failure to produce heat- or lysozyme-resistant spores. Spore formation was arrested at stage III-IV with the production of limited numbers of phase-grey spores. This phenotype was essentially asporogenous and indistinguishable from the null spoIVB
::spc mutant. The pDG364 plasmids carrying these mutant alleles were introduced into spo+ cells (strain PY79) and in each case we found that the resulting phenotype was Spo+, showing that the mutation was recessive to the wild-type spoIVB gene when placed at its normal chromosomal position (data not shown).
The second phenotypic class (group II) was made up of strains carrying the spoIVBDL213, spoIVBDL240, spoIVBDN242, spoIVBKA321, spoIVBDN363, and spoIVBKA387 alleles. Cells carrying these mutations produced normal levels of heat- and lysozyme-resistant spores and were essentially indistinguishable from the isogenic Spo+ strain, NH578. Spores produced in these mutants were able to germinate normally.
The final and most interesting mutant class (group III) comprised the spoIVBNI290 and spoIVBHD394 mutations. They formed phase-bright spores, and so were Spo+, but there was a marked and reproducible reduction in the level of spores produced (approximately 30% fewer spores than in the wild-type strain). For these mutants we examined the capacity of spores to germinate and found that they were germination defective. Further analysis revealed that for spoIVBNI290 this germination defect was temperature sensitive, since the mutant was unable to germinate properly at 37°C. In other work we have shown that bofA and bofB mutations (in BofA and SpoIVFA, respectively) allow constitutive activation of SpoIVFB and therefore pro-
K processing (8). This, in turn, leads to premature
K-controlled gene expression, a reduction in spore-forming efficiency, and for those spores that are formed (approximately 10% of the total CFU), a defective germination response. This phenotype is most probably caused by a defect in spore coat assembly, which is controlled by the
K regulon. We reasoned that the reduced sporulation efficiency and defective germination response of the NI290 and HD394 mutants could be caused by a defect in signaling.
K-directed gene expression.
To examine signaling in the
K checkpoint we used a
K-transcribed reporter gene, gerE-lacZ (9). Lysogenized cells carrying mutant alleles with the SPßgerE-lacZ reporter phage were examined for gerE-directed ß-galactosidase synthesis during spore formation (Fig. 2). For the spoIVB null mutant (SC1836 spoIVB
::spc) we detected low levels (less than 15%) of
K-directed gene expression, in agreement with previous work, while for spo+ cells, gerE-lacZ expression started at about 3.5 to 4 h after the initiation of spore formation. Our results define three clear classes of mutant gene expression, with (i) a block in
K-directed gene expression, (ii) no effect on
K-directed gene expression, and (iii) delayed and reduced levels of expression. These mutant phenotypes correspond exactly to the groups classified above according to their ability to sporulate.
![]() View larger version (16K): [in a new window] |
FIG. 2. gerE-lacZ expression in spoIVB mutants. ß-Galactosidase synthesis was measured at the indicated times following the initiation of sporulation in cells carrying the SPßgerE::lacZ reporter phage. In each case congenic strains were used and the relevant alleles (at the amyE locus) are given here (see Table 1 for complete genotypes). (A) , NH578, spoIVB+; , NH577, spoIVB ::spc; , NH1326, spoIVBDL363; , NH1328, spoIVBSK378; , NH1320, spoIVBHN236; , NH1346, spoIVBDL242. (B) , NH578, spoIVB+; , NH577, spoIVB ::spc; , NH1345, spoIVBDL240; , NH1347, spoIVBNI290; , NH1330, spoIVBHD394; , NH1377, spoIVBDL213; , NH1380, spoIVBKA321. (C) , NH578, spoIVB+; , NH577, spoIVB ::spc; , NH1451, spoIVBHF236; , NH1452, spoIVBDN242; , NH1453, spoIVBDN363; , NH1454, spoIVBSA378; , NH1455, spoIVBKA387.
|
K, leading to premature
K-directed gene expression. Although other alleles within spoIVB have been shown to lead to delayed signaling (14, 17), the clear delay seen in the spoIVBHN394 and spoIVBNI290 mutations reinforces the notion that the role of this checkpoint is as a timing mechanism. That signaling does occur accounts for the levels of phase-bright spores that are produced.
Proteolysis of SpoIVB.
To determine the effect of our collection of mutations on proteolysis we examined SpoIVB during spore formation using a polyclonal antiserum (Fig. 3). Previous work has shown that SpoIVB is synthesized as a 50-kDa polypeptide at about the second hour of sporulation (36). Starting at hour 3, SpoIVB is cleaved into a number of products (approximately 46, 45, and 44 kDa), one or more of which is the active form that signals SpoIVFB-mediated processing of pro-
K. Almost simultaneously, these forms are subject to secondary proteolysis, which presumably inactivates the active forms by cleavage to 42- and 40-kDa species which are then cleaved further. During sporulation, then, in wild-type cells, we see the 50-kDa species briefly but at hour 3 autoproteolysis has begun producing the active species as well as the inactive forms.
![]() View larger version (49K): [in a new window] |
FIG. 3. Proteolysis of SpoIVB in B. subtilis. Sporulation was induced in wild-type (spo+), spoIVB ::spc ( spo), and spoIVB mutant strains. Panel A shows an experiment examining strains carrying nonconservative mutations, and panel B shows strains carrying conservative changes as well as the alteration KA387. Samples of sporulating cells were taken at the times indicated, cells were lysed, and equivalent amounts of cellular protein were fractionated by SDS-PAGE (12%) and examined with a polyclonal antiserum to SpoIVB (2-min enhanced chemiluminescence exposure time). The full-length, 50-kDa, unprocessed form of SpoIVB is marked, as are 46-, 45-, and 44-kDa intermediate SpoIVB cleavage products and the 42- and 40-kDa cleavage products produced by secondary cleavage.
|
(i) His236 and Ser378. Compared to spo+ cells, in HN236 (Fig. 3A), HF236 (Fig. 3B), SK378 (Fig. 3A), and SA378 (Fig. 3B) mutants, the 50-kDa SpoIVB protein was cleaved less quickly and appeared to be maintained longer in its full-length form. Compared to spo+ cells the 50-kDa species appeared to undergo proteolysis approximately 30 min later as judged by the appearance of the 40- to 42-kDa species. This corresponds to hour 3 using our sampling regimen shown in Fig. 3. We must emphasize that differences in actual processing time compared to previous studies (36) are empirical and must be taken in the context of processing relative to that in spo+ cells. With some mutants such as KA387 (Fig. 3B) and DL213 (Fig. 3A) there appeared to be slightly more of the 50-kDa species than with spo+ cells at the same time points. However, processing initiated at the same time as in spo+ cells (2.5 h). To confirm that proteolysis was defective in these mutant proteins, we expressed the HN236 and SK378 SpoIVB mutants from pET28b expression vectors in E. coli BL21(DE3) and examined expressed proteins by SDS-PAGE. As shown in Fig. 4, expression led to the accumulation of a stable, full-length 50-kDa SpoIVB species. In contrast, expression of a wild-type SpoIVB template produced little or no detectable SpoIVB protein as it is subject to rapid self-cleavage in E. coli (36).
![]() View larger version (55K): [in a new window] |
FIG. 4. Expression of mutant SpoIVB proteins in E. coli. E. coli BL21 (DE3) cells harboring pET28b vectors with a wild-type (WT) SpoIVB or mutant genes (spoIVBHN236, spoIVBDL242, spoIVBDL363, and spoIVBSK378) were grown and gene expression was induced with isopropyl-ß-d-thiogalactopyranoside (IPTG). Samples taken before induction (T0) and at hours 1 (T1) and 2 (T2) postinduction were fractionated by SDS-PAGE (12.5%). The full-length 50-kDa SpoIVB precursor protein is indicated by an arrow.
|
K normally.
(iii) Asp242.
We are unable to detect any SpoIVB DL242 mutant protein in B. subtilis (Fig. 3A). We have repeated this experiment a number of times and conclude that this mutant protein is unstable and presumably is rapidly cleared by secondary proteolysis. We confirmed this, in part, by expressing the SpoIVB DL242 protein in E. coli (Fig. 4), which showed that the mutant protein behaves differently from the wild-type protein, accumulating as a 35- to 40-kDa species. The aberrant molecular mass of this SpoIVB DL242 species implies that self-cleavage is defective and/or the protein is unstable. The latter deduction could arise if the structure of the mutant polypeptide is abnormal. This corresponds with our results showing that signaling is defective in spoIVBDL242 cells. In contrast, a conservative amino acid substitution at this position (Asp242 to Asn) allows normal signaling in the
K checkpoint, and proteolysis of the SpoIVB DN242 protein appears normal.
(iv) Asn290 (Fig. 3A) and His394 (Fig. 3A). Processing of these SpoIVB mutant proteins appeared essentially normal, although there was perhaps a slight accumulation of the 50-kDa species in spoIVBHD394 cells. Although signaling is delayed in spoIVBNI290 and spoIVBHD394 mutants, we assume that the subtle change or delay in SpoIVB processing is not detectable by the 30-min sampling regimen used here.
(v) Asp363.
Proteolysis appeared to be delayed by 30 min in spoIVBDL363 mutant cells (Fig. 3A). Also, there appeared to be considerably less SpoIVB protein detectable by Western blotting. Expression of SpoIVB DL363 in E. coli showed a clear accumulation of a full-length 50-kDa precursor, showing that processing was defective. In contrast, processing in the mutant with a conservative replacement (SpoIVB DN363) was normal (Fig. 3B), as was signaling of pro-
K processing.
|
|
|---|
K processing as well as inhibiting the proteolytic activity of SpoIVB. As mentioned below it must be stressed that proteases can retain residual activity even when active site residues are altered (20). The order and spacing of His236 and Ser378 agree with serine peptidases of the trypsin superfamily (1, 23) and make the essential catalytic unit approximately 160 amino acid residues contained at the C terminus of SpoIVB. The GMSG motif surrounding Ser378 closely resembles trypsin, but it is a distinct variant as this family typically has a residue with negative charge (Asp or Glu) preceding the active site serine (1, 23). In contrast, there is little similarity in sequence around the active site SpoIVB His236 residue with other trypsin family members, suggesting that SpoIVB must be a member of a new family of the PA(S) clan. We have identified one Asp residue, Asp363, for which mutation to Leu leads to a lack of SpoIVB self-cleavage and signaling properties. Another Asp residue, Asp242, when mutated to Leu also blocked signaling yet failed to accumulate any protein at all, suggesting that the mutation rendered the protein unstable. We have noticed a DxxLL motif which is present in a number of serine peptidase families, especially those of the PA(S) clan (23, 24), and is found at position 363, and we take this as evidence that the SpoIVB serine peptidase has a catalytic triad with Asp363 as its third member. Intriguingly, a conservative change at this position does not disrupt proteolysis of the SpoIVB protein. The acidic residue is the least important component of the active site triad in serine peptidases, and Asp is replaced by Glu in carboxyl peptidase (37) and aspartyl dipeptidase (13). In the case of cytomegalovirus protease, histidine acts as the acid in a unique Ser-His-His triad. Mutation of cytomegalovirus protease His157 reduces activity only 5- to 10-fold (33). In contrast, catalysis by trypsin-like enzymes is severely impaired when the acidic residue is replaced by mutation, suggesting that the negative charge of the Asp side chain balances the positive charge that develops on the histidine during catalysis (6). In some systems, however, the Asp simply serves to maintain the correct position of the active site histidine. Indeed, in cysteine proteases, a conserved Asn residue (e.g., Asn175 in papain) serves this very purpose (35) and Asn156 appears in the hydrolase catalytic triad of E. coli outer membrane phospholipase A (15). We assume that the role of Asp363 is to stabilize the appropriate His263 rotamer or tautomer in SpoIVB catalysis, a function that could potentially be performed by Asn. The unusually close spacing of Asp363 to Ser378, its ability to be replaced by Asn, and the lack of a consensus motif around His236 all argue that SpoIVB represents a new family of serine peptidases.
One observation we have made here is that mutations that block signaling of pro-
K processing underwent proteolysis in B. subtilis to yield intermediate forms. We have not noticed this before with a different spoIVBSA378 mutant which was placed at the spoIVB locus (36). We believe that one possible explanation is that even though an active site residue is mutated, the protease can still retain residual proteolytic activity (20). Despite mutation of all three members of the catalytic His-Asp-Ser triad of subtilisin, enzymatic activity is still approximately 103 to 104 times the noncatalyzed rate (5). Our in vivo work shows that changes at His236, Asp363, and Ser378 do appear to allow limited self-cleavage of SpoIVB to forms of approximately 46, 45, and 44 kDa. We had previously predicted that these might represent active forms but we must now question this model. It is possible, though, that the 44- to 46-kDa species observed in these mutants are actually inactive forms brought about by incorrect cleavage or by secondary proteolysis. Alternatively, residual enzyme activity is sufficient to permit self-cleavage but at levels too low to permit signaling. Our work does show clearly, though, that all nonsignaling mutants show delayed cleavage of the full-length form of SpoIVB, and we wonder whether signaling can occur only during a precise window of time concurrent with release of SpoIVB from the inner forespore membrane by self-cleavage. This latter event would occur following the first cut, and for signaling this is presumably then the most important event, enabling release of SpoIVB. In the nonsignaling mutants, though, we reason that self-processing is substantially reduced, leading to a delayed appearance of intermediate species, at which time the SpoIVFB processing complex is no longer responsive (or competent) to cleave pro-
K.
The results of mutation at residues Asn290 and His394 are more difficult to interpret. Our work suggests that proteolysis of these mutants was less potent, leading to delayed signaling. Possible explanations include roles for these residues in ground state substrate binding or stabilization of the reaction transition state by forming an oxyanion hole reminiscent of Asn155 in subtilisin. Mutation of this sidechain leads to a 200- to 300-fold reduction in turnover number of this serine peptidase (4). A similar role for Asn290 might explain a delay in signaling.
We are presently attempting to determine the crystal structure of SpoIVB, which will enable us to test our prediction that Asp363 is suitably placed to comprise the third member of a catalytic triad and to assess the importance of residues Asn290 and His394 in SpoIVB function. We will also explore the role of the PDZ domain in relation to the peptidase activity. A survey of bacterial proteins with PDZ domains suggests that of 187 non-SpoIVB bacterial PDZ-containing proteins, remarkably only 9 are predicted not to contain transit peptides or transmembrane segments. More surprising is that only 28 are not associated with a protease activity, i.e., 85% of all known PDZ-containing bacterial proteins are also proteases (Fig. 5), indicating that they have evolved a specialized role in association with peptidase activity due to their ability to traverse a membrane for (i) localization and (ii) substrate specificity, and thus are ideal for the signaling function of SpoIVB.
![]() View larger version (24K): [in a new window] |
FIG. 5. Bacterial proteases with PDZ domains. Bacterial PDZ-containing proteins detected by the simple modular architecture research tool (SMART) (31) that are associated with peptidase activity are represented schematically with the number of proteins (as of June 2001) of each type indicated. Non-SpoIVB proteins are classified into three groups characterized by trypsin modules (Trp), carboxyl-terminal processing peptidases (Tsp), or zinc metallopeptidases (Zn). For simplicity, ST represents either a signal or transit peptide or a membrane-spanning segment. Also, only the transmembrane segments (TM) that are accurately predicted by SMART are represented for ease of comparison.
|
This work was supported by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC) to S.M.C. J.A.B. is supported by the BBSRC-funded Structural Biology Centre at York.
|
|
|---|
K processing in Bacillus subtilis. Genes Dev. 5:456466.
K processing complex. J. Bacteriol. 182:278285.
K. J. Bacteriol. 181:53845388.
K processing during sporulation in Bacillus subtilis. J. Bacteriol. 174:31773184.
K processing. Microbiology 143:10531058.
K processing in Bacillus subtilis. Mol. Microbiol. 36:13361348.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»